• Pentoxifylline Attenuates LPS-Induced Hyperinflammation in N

  2026-04-30

  This study provides mechanistic insight into how Pentoxifylline, a non-specific phosphodiesterase inhibitor, modulates hyperinflammatory responses in monocytes from preterm infants exposed to bacterial LPS in vitro. The findings highlight age-dependent immunomodulatory effects, with implications for neonatal sepsis research and future therapeutic strategies.

• Pomalidomide (CC-4047): Optimizing Hematological Malignancy

  2026-04-30

  Pomalidomide (CC-4047) enables precision modulation of the tumor microenvironment and erythroid differentiation in hematological malignancy research. This article details advanced workflows, essential troubleshooting, and evidence-backed protocol parameters, translating recent genomic insights into actionable laboratory strategies.

• MitMAB (SKU B7620): Precision Inhibition for Endocytosis Res

  2026-04-29

  This article addresses practical challenges in cell-based endocytosis and cytotoxicity assays, illustrating how MitMAB (SKU B7620) delivers reliable and reproducible inhibition of dynamin GTPase activity. Scenario-driven insights guide researchers in optimizing intracellular trafficking studies and highlight MitMAB's evidence-backed performance in physiologically relevant organoid models.

• Neuromedin S (rat): Technical Guidance for GPCR Signaling As

  2026-04-29

  Neuromedin S (rat) provides a defined endogenous ligand for activating neuromedin U receptor signaling in controlled GPCR/G protein assays. This product addresses the need for reproducible, validated peptide reagents in studies of energy homeostasis and stress response in rat models. It is intended solely for research use and is not suitable for diagnostic or therapeutic applications.

• HyperFluor™ 488 Goat Anti-Rabbit IgG: Technical Use & QC Gui

  2026-04-28

  HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody addresses the need for sensitive and specific detection of rabbit primary antibodies in fluorescence-based assays. It is best suited for immunofluorescence, flow cytometry, and microscopy where high signal amplification and low cross-reactivity are required. This reagent is not suitable for applications outside its validated scope, such as direct detection of non-rabbit primaries or non-fluorescent workflows.

• Baicalein for Apoptosis and Inflammation: Applied Workflows

  2026-04-28

  Baicalein (5,6,7-trihydroxy-2-phenylchromen-4-one) stands out as a high-purity research compound for dissecting apoptosis and inflammation pathways, thanks to its potent inhibition of arachidonic acid metabolism. This guide delivers actionable protocols, troubleshooting strategies, and comparative insights to maximize experimental rigor and reproducibility.

• Protoporphyrin IX: Optimizing Photodynamic Workflows in Canc

  2026-04-27

  Protoporphyrin IX enables high-precision modeling of iron metabolism, ferroptosis, and advanced photodynamic cancer diagnostics. This article translates the latest mechanistic insights and validated protocols into actionable steps for researchers, highlighting troubleshooting strategies and comparative advantages with APExBIO’s high-purity formulation.

• Trelagliptin Succinate Improves Insulin Resistance via PI-3K

  2026-04-27

  This study elucidates trelagliptin succinate’s capacity to ameliorate insulin resistance in adipocytes by enhancing the PI-3K/AKT/GLUT4 signaling pathway and reducing key adipokines. The findings clarify molecular mechanisms of DPP-4 inhibition for metabolic disease research and offer an improved workflow for phosphorylation-state analysis.

• Practical Guide to YC-1 (5-(1-benzyl-1H-indazol-3-yl)furan-2

  2026-04-26

  YC-1 (5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol is a research-grade sGC activator and HIF-1α inhibitor, supporting experiments focused on hypoxia signaling, tumor angiogenesis, and apoptosis in cancer biology. It should be used in workflows where post-transcriptional inhibition of HIF-1α or modulation of cGMP is relevant, but is not intended for diagnostic or clinical applications.

• Cy5 NHS ester(Et): Technical Guidance for Fluorescent Labeli

  2026-04-25

  Cy5 NHS ester(Et) is designed for robust, water-soluble fluorescent labeling of primary amines on biomolecules, notably enhancing protein fluorescent labeling and immunofluorescence workflows. It should not be used for ethanol-based protocols or where long-term storage of working solutions is required.

• U0126-EtOH: Selective MEK1/2 Inhibitor for Neuroprotection &

  2026-04-24

  U0126-EtOH is a gold-standard MEK1/2 inhibitor enabling precise dissection of the MAPK/ERK pathway in neuroprotection and inflammatory research. This guide details optimized experimental workflows, troubleshooting strategies, and the latest evidence from mechanistic studies—empowering scientists to harness U0126-EtOH for advanced cellular and in vivo models.

• TG003 Cdc2-like Kinase Inhibitor: Applied Splicing Modulatio

  2026-04-24

  TG003 Cdc2-like kinase inhibitor empowers researchers to dissect alternative splicing mechanisms and overcome platinum resistance in cancer models with unmatched selectivity and reproducibility. This guide delivers stepwise protocols, evidence-based troubleshooting, and translational insights for workflow optimization using APExBIO's trusted reagent.

• Dabigatran Etexilate: Advancing Oral Anticoagulation Strateg

  2026-04-23

  This review examines the clinical and pharmacological advancements of dabigatran etexilate, the first marketed oral direct thrombin inhibitor, as detailed in Blommel & Blommel (2011). The paper’s findings highlight the drug’s predictable pharmacokinetics, reduced need for monitoring, and its potential to address significant limitations of older anticoagulant therapies.

• Ibrexafungerp (MK 3118): Applied Antifungal Workflows & Trou

  2026-04-23

  Ibrexafungerp (MK 3118) is redefining antifungal research, offering potent activity against resistant Candida including echinocandin-resistant clinical isolates. This article delivers actionable experimental workflows, troubleshooting strategies, and protocol enhancements to help researchers maximize translational impact using this novel oral antifungal.

• Pomalidomide (CC-4047): Benchmarks in Multiple Myeloma Resea

  2026-04-22

  Pomalidomide (CC-4047) is a potent immunomodulatory and antineoplastic agent optimized for hematological malignancy research. Its precise modulation of cytokine release and direct antitumor activity make it a cornerstone for investigating multiple myeloma cell biology. APExBIO's SKU A4212 provides validated, reproducible results in complex tumor microenvironment studies.

16513 records 1/1101 page Next 12345 下5页 Last page